BioNTech SE (NASDAQ:BNTX) Receives $142.72 Average Target Price from Brokerages
Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, thirteen have issued a buy recommendation and one has assigned a strong buy […]
Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, thirteen have issued a buy recommendation and one has assigned a strong buy […]
